© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
November 03, 2020
The first 3 months of the pandemic were marked by a significant rate of patients changing or discontinuing medication without clinician guidance.
New data show patients with arthritis and psoriasis are far more likely to quarantine and isolate than similar patients, differentiating by treatment type.
November 02, 2020
New data from ACR 2020 assure concerns that patients with arthritis who test positive for COVID-19 may be at worse risk of ICU admission or even death.
Risk of herpes zoster and creatine phosphokinase increased with use of upadacitinib.
October 06, 2020
The assessed sickle cell population had high rates of low vitamin D levels and bone marrow density, but there was no strong correlation between both conditions.
September 30, 2020
This approval makes the drug the first of its kind to treat polyarticular juvenile idiopathic arthritis and psoriatic arthritis in a pediatric population.
September 18, 2020
Findings indicate placebo responses are more than a psychological placebo effect.
September 16, 2020
An expert discusses the difficulties in diagnosing and managing myositis, as well as how the COVID-19 pandemic has affected clinical care.
Three key issues with using the technology over in-person visits.
September 15, 2020
Care of rheumatic patients must factor in cradiovascular risk and conditions.